Cornell Pochily Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $681K | Buy |
28,268
+585
| +2% | +$15.3K | 0.18% | 105 |
|
|
2026
Q1 | $777K | Sell |
27,683
-1,409
| -5% | -$37.5K | 0.23% | 88 |
|
|
2025
Q4 | $724K | Sell |
29,092
-1,111
| -4% | -$28K | 0.21% | 94 |
|
|
2025
Q3 | $770K | Buy |
30,203
+564
| +2% | +$13.9K | 0.23% | 93 |
|
|
2025
Q2 | $718K | Sell |
29,639
-78
| -0.3% | -$1.82K | 0.24% | 95 |
|
|
2025
Q1 | $753K | Sell |
29,717
-2,119
| -7% | -$55.4K | 0.26% | 92 |
|
|
2024
Q4 | $845K | Sell |
31,836
-3,335
| -9% | -$90.5K | 0.29% | 85 |
|
|
2024
Q3 | $1.02M | Buy |
35,171
+20,314
| +137% | +$593K | 0.35% | 73 |
|
|
2024
Q2 | $416K | Buy |
14,857
+1,581
| +12% | +$43.5K | 0.16% | 122 |
|
|
2024
Q1 | $368K | Sell |
13,276
-81
| -0.6% | -$2.25K | 0.15% | 127 |
|
|
2023
Q4 | $385K | Sell |
13,357
-1,979
| -13% | -$59.8K | 0.16% | 127 |
|
|
2023
Q3 | $509K | Sell |
15,336
-1,197
| -7% | -$42.3K | 0.22% | 103 |
|
|
2023
Q2 | $606K | Hold |
16,533
| – | – | 0.25% | 100 |
|
|
2023
Q1 | $675K | Sell |
16,533
-1,606
| -9% | -$69.4K | 0.29% | 98 |
|
|
2022
Q4 | $929K | Sell |
18,139
-340
| -2% | -$16.3K | 0.42% | 74 |
|
|
2022
Q3 | $809K | Sell |
18,479
-1,425
| -7% | -$69.2K | 0.35% | 80 |
|
|
2022
Q2 | $1.04M | Hold |
19,904
| – | – | 0.47% | 68 |
|
|
2022
Q1 | $1.03M | Sell |
19,904
-320
| -2% | -$16.6K | 0.4% | 78 |
|
|
2021
Q4 | $1.19M | Sell |
20,224
-445
| -2% | -$22K | 0.46% | 62 |
|
|
2021
Q3 | $889K | Buy |
20,669
+1,579
| +8% | +$70K | 0.38% | 75 |
|
|
2021
Q2 | $748K | Buy |
19,090
+1,803
| +10% | +$70.1K | 0.33% | 83 |
|
|
2021
Q1 | $626K | Buy |
17,287
+1,650
| +11% | +$58.6K | 0.3% | 84 |
|
|
2020
Q4 | $576K | Buy |
15,637
+1
| +0% | +$37 | 0.28% | 83 |
|
|
2020
Q3 | $544K | Buy |
15,636
+594
| +4% | +$20.8K | 0.31% | 83 |
|
|
2020
Q2 | $467K | Buy |
15,042
+5
| +0% | +$170 | 0.29% | 85 |
|
|
2020
Q1 | $466K | Sell |
15,037
-376
| -2% | -$12.8K | 0.35% | 78 |
|
|
2019
Q4 | $573K | Sell |
15,413
-197
| -1% | -$7.02K | 0.34% | 80 |
|
|
2019
Q3 | $532K | Sell |
15,610
-4,251
| -21% | -$155K | 0.34% | 84 |
|
|
2019
Q2 | $916K | Buy |
19,861
+4,612
| +30% | +$183K | 0.23% | 60 |
|
|
2019
Q1 | $614K | Sell |
15,249
-3,554
| -19% | -$142K | 0.42% | 65 |
|
|
2018
Q4 | $778K | Buy |
18,803
+6,500
| +53% | +$270K | 0.5% | 58 |
|
|
2018
Q3 | $514K | Sell |
12,303
-1,137
| -8% | -$43.8K | 0.35% | 76 |
|
|
2018
Q2 | $462K | Sell |
13,440
-5,448
| -29% | -$186K | 0.32% | 78 |
|
|
2018
Q1 | $636K | Buy |
18,888
+2,495
| +15% | +$85.8K | 0.45% | 68 |
|
|
2017
Q4 | $563K | Buy |
+16,393
| New | +$559K | 0.36% | 79 |
|
Other funds holding PFE
Cornell Pochily Investment Advisors's PFE Position: Q2 2026 in Review
Cornell Pochily Investment Advisors increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $15.3K and bringing the position to 28,268 shares worth $681K. The position accounts for 0.18% of the portfolio, ranked #105.
Cornell Pochily Investment Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.19M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cornell Pochily Investment Advisors held 28,268 shares of Pfizer worth $681K as of Q2 2026.
- Cornell Pochily Investment Advisors bought 585 Pfizer shares in Q2 2026, an estimated $15.3K.
- Pfizer made up 0.18% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #105 holding.
- Cornell Pochily Investment Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Cornell Pochily Investment Advisors's Pfizer position peaked at $1.19M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.